A Somerset man who was diagnosed with incurable blood cancer thanks the Taunton and Yeovil NHS teams who have been given an award for ...

Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

EDINBURGH, UK I January 15, 2025 I Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced ...

The humanised trispecific antibody is undergoing Phase I trials in the US and China in subjects with relapsed or refractory ...

Researchers sought to determine whether patients who are functional high-risk had a worse prognosis even without having traditional high-risk features.